论文部分内容阅读
129例T2DM住院患者,使用甘精胰岛素联合口服降糖药治疗。结果治疗后空腹血糖和餐后2小时血糖均显著下降;两两相关检验的显示,甘精胰岛素每日剂量与年龄、体重、身高、糖化血红蛋白、空腹血糖、餐后2小时血糖之间有显著相关性;经回归方程分析,回归系数P值小于0.05的有体重和空腹血糖,甘精胰岛素每日剂量与体重、空腹血糖之间有线性关系。低血糖发生率低。结论使用甘精胰岛素联合口服降糖药治疗2型糖尿病T2DM患者可良好控制血糖。
129 patients with T2DM were hospitalized with insulin glargine and oral hypoglycemic agents. Results After treatment, fasting blood glucose and postprandial blood glucose 2 hours were significantly decreased; two pairs of related tests showed that glargine daily dose and age, weight, height, HbAlc, fasting blood glucose, 2 hours postprandial blood glucose were significantly Correlation; regression equation analysis, regression coefficient P value of less than 0.05 with body weight and fasting blood glucose, insulin glargine daily dose and body weight, fasting blood glucose has a linear relationship. Low incidence of hypoglycemia. Conclusion Glargine and oral hypoglycemic agents can be used to control blood glucose in T2DM patients with type 2 diabetes mellitus.